Toward understanding cancer stem cell heterogeneity in the tumor microenvironment
The epithelial–mesenchymal transition (EMT) and cancer stem cell (CSC) formation are two
paramount processes driving tumor progression, therapy resistance, and cancer metastasis …
paramount processes driving tumor progression, therapy resistance, and cancer metastasis …
Toward understanding cancer stem cell heterogeneity in the tumor microenvironment.
F Bocci, L Gearhart-Serna, M Boareto… - Proceedings of the …, 2018 - europepmc.org
Results A Gradient of EMT-Inducing Signal Recapitulates the Experimentally Observed
Spatial Segregation of Different EMT Phenotypes. The interplay of different …
Spatial Segregation of Different EMT Phenotypes. The interplay of different …
Toward understanding cancer stem cell heterogeneity in the tumor microenvironment.
F Bocci, L Gearhart-Serna, M Boareto… - Proceedings of the …, 2019 - sonar.ch
English The epithelial-mesenchymal transition (EMT) and cancer stem cell (CSC) formation
are two paramount processes driving tumor progression, therapy resistance, and cancer …
are two paramount processes driving tumor progression, therapy resistance, and cancer …
Toward understanding cancer stem cell heterogeneity in the tumor microenvironment
F Bocci, L Gearhart-Serna, M Boareto… - Proceedings of the …, 2019 - ui.adsabs.harvard.edu
The presence of heterogeneous subsets of cancer stem cells (CSCs) remains a clinical
challenge. These subsets often occupy different regions in the primary tumor and have …
challenge. These subsets often occupy different regions in the primary tumor and have …
Toward understanding cancer stem cell heterogeneity in the tumor microenvironment
F Bocci, L Gearhart-Serna, M Boareto, M Ribeiro… - Proceedings of the …, 2019 - JSTOR
The epithelial–mesenchymal transition (EMT) and cancer stem cell (CSC) formation are two
paramount processes driving tumor progression, therapy resistance, and cancer metastasis …
paramount processes driving tumor progression, therapy resistance, and cancer metastasis …
Toward understanding cancer stem cell heterogeneity in the tumor microenvironment
F Bocci, L Gearhart-serna… - … of the National …, 2019 - research.manchester.ac.uk
The epithelial–mesenchymal transition (EMT) and cancer stem cell (CSC) formation are two
paramount processes driving tumor progression, therapy resistance, and cancer metastasis …
paramount processes driving tumor progression, therapy resistance, and cancer metastasis …
Toward understanding cancer stem cell heterogeneity in the tumor microenvironment
F Bocci, L Gearhart-Serna, M Boareto… - … OF THE NATIONAL …, 2019 - bv.fapesp.br
The epithelial-mesenchymal transition (EMT) and cancer stem cell (CSC) formation are two
paramount processes driving tumor progression, therapy resistance, and cancer metastasis …
paramount processes driving tumor progression, therapy resistance, and cancer metastasis …
Toward understanding cancer stem cell heterogeneity in the tumor microenvironment.
F Bocci, L Gearhart-Serna, M Boareto… - Proceedings of the …, 2019 - folia.unifr.ch
English The epithelial-mesenchymal transition (EMT) and cancer stem cell (CSC) formation
are two paramount processes driving tumor progression, therapy resistance, and cancer …
are two paramount processes driving tumor progression, therapy resistance, and cancer …
Toward understanding cancer stem cell heterogeneity in the tumor microenvironment
F Bocci, L Gearhart-Serna… - Proceedings of the …, 2019 - pubmed.ncbi.nlm.nih.gov
The epithelial-mesenchymal transition (EMT) and cancer stem cell (CSC) formation are two
paramount processes driving tumor progression, therapy resistance, and cancer metastasis …
paramount processes driving tumor progression, therapy resistance, and cancer metastasis …
Toward understanding cancer stem cell heterogeneity in the tumor microenvironment
F Bocci, L Gearhart-Serna, M Boareto… - … OF THE NATIONAL …, 2019 - eprints.iisc.ac.in
The epithelial-mesenchymal transition (EMT) and cancer stem cell (CSC) formation are two
paramount processes driving tumor progression, therapy resistance, and cancer metastasis …
paramount processes driving tumor progression, therapy resistance, and cancer metastasis …